GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 256 filers reported holding GW PHARMACEUTICALS PLC in Q2 2018. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $9,067,000 | +27.0% | 64,976 | +2.5% | 0.04% | +25.8% |
| Q1 2018 | $7,142,000 | -39.9% | 63,392 | -29.6% | 0.03% | -43.6% |
| Q4 2017 | $11,881,000 | +260.6% | 90,000 | +177.2% | 0.06% | +223.5% |
| Q3 2017 | $3,295,000 | -5.5% | 32,462 | -6.7% | 0.02% | -19.0% |
| Q2 2017 | $3,488,000 | +86.0% | 34,794 | +124.5% | 0.02% | +40.0% |
| Q1 2017 | $1,875,000 | +37.2% | 15,500 | +50.5% | 0.02% | +50.0% |
| Q3 2016 | $1,367,000 | +199.1% | 10,300 | +106.0% | 0.01% | +400.0% |
| Q3 2015 | $457,000 | -93.7% | 5,000 | -91.5% | 0.00% | -95.5% |
| Q2 2015 | $7,260,000 | +34.3% | 59,100 | -0.3% | 0.04% | +7.3% |
| Q1 2015 | $5,404,000 | -23.6% | 59,300 | -10.0% | 0.04% | -39.7% |
| Q2 2014 | $7,071,000 | +3400.5% | 65,900 | +1838.2% | 0.07% | +3300.0% |
| Q1 2014 | $202,000 | – | 3,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Copernicus Capital Management, LLC | 52,488 | $5,110,000 | 4.87% |
| GREAT POINT PARTNERS LLC | 520,232 | $50,645,000 | 4.56% |
| Integral Health Asset Management, LLC | 65,000 | $6,328,000 | 1.94% |
| CLOUGH CAPITAL PARTNERS L P | 190,716 | $18,566,000 | 1.34% |
| Parkman Healthcare Partners LLC | 50,000 | $4,868,000 | 1.29% |
| ETF MANAGERS GROUP, LLC | 375,344 | $36,540,000 | 1.16% |
| Redwood Investments, LLC | 124,094 | $12,081,000 | 1.02% |
| Eventide Asset Management | 436,000 | $42,445,000 | 0.83% |
| Bellevue Group AG | 562,943 | $54,803,000 | 0.76% |
| ROOSEVELT INVESTMENT GROUP LLC | 95,499 | $9,297,000 | 0.75% |